Literature DB >> 11444023

Correlates of protection against rotavirus infection and disease.

P A Offit1.   

Abstract

Repeated infections with the 'mucosal' pathogen rotavirus are common in children. Subsequent rotavirus infections usually cause milder symptoms than first-time infections. Therefore, although natural rotavirus infection attenuates the severity of subsequent infections, it does not prevent reinfection or mild disease. On the other hand, natural infection with 'systemic' viruses such as measles, mumps, rubella, or varicella often confers life-long protection against mild disease associated with reinfection. The degree to which differences in the pathogenesis of systemic and mucosal pathogens determines differences in the capacity of natural infection to induce life-long protective immunity will be discussed. This paradigm will be used to explore the immunological effector functions associated with protection against rotavirus challenge.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444023     DOI: 10.1002/0470846534.ch8

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  5 in total

1.  Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity.

Authors:  Sarah E Blutt; Kelly L Warfield; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

2.  CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells.

Authors:  Eric J Kunkel; Chang H Kim; Nicole H Lazarus; Mark A Vierra; Dulce Soler; Edward P Bowman; Eugene C Butcher
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Authors:  Sarah E Blutt; Sue E Crawford; Kelly L Warfield; Dorothy E Lewis; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization.

Authors:  Hye Suk Hwang; Sao Puth; Wenzhi Tan; Vivek Verma; Kwangjoon Jeong; Shee Eun Lee; Joon Haeng Rhee
Journal:  Hum Vaccin Immunother       Date:  2018-06-19       Impact factor: 3.452

Review 5.  The gastrointestinal frontier: IgA and viruses.

Authors:  Sarah E Blutt; Margaret E Conner
Journal:  Front Immunol       Date:  2013-11-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.